Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

clinprost

Known as: isocarbacyclin methyl ester 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
A step-economical synthesis of clinprost is reported that concludes with 3 different transition metal-catalyzed reactions: Pd… Expand
  • figure 1
1997
1997
TTC-909 (Clinprost), a chemically stable PGI2 analog, isocarbacyclin methyl ester (TEI-9090 or Clinprost) incorporated in lipid… Expand
1996
1996
TTC-909 is a newly developed isocarbacyclin methyl ester (TEI-9090) incorporated in lipid microspheres. The neuroprotective… Expand
1996
1996
Because the permeability of the blood‐brain barrier to lipid microspheres (LMs) has not hitherto been demonstrated, blood‐brain… Expand
Highly Cited
1995
Highly Cited
1995
Species differences in the hydrolysis of isocarbacyclin methyl ester (TEI-9090) in whole blood and in its separated components… Expand
1995
1995
The effect of TTC-909 (isocarbacyclin methyl ester (CAS 88931-51-5, TEI-9090) incorporated into lipid microspheres) on… Expand
1995
1995
The binding affinities of isocarbacyclin methyl ester (CAS 88931-51-5, TEI-9090) and its free acid (CAS 88911-35-7, TEI-7165) to… Expand
1995
1995
TTC-909 is a preparation of isocarbacyclin methyl ester (CAS 88931-51-5, TEI-9090) incorporated into lipid microspheres. The… Expand
1994
1994
Abstract— An adsorption technique with polydimethylsiloxane‐coated glass beads (PDMS‐GB) was developed to determine the protein… Expand
1987
1987
The effects of prostacyclin (PGI2) and stable derivatives of PGI2, such as isocarbacyclin (PGI2 deriv. (A] and isocarbacyclin… Expand